FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Perrigo basic+care Recall

basic+care, allergy Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 24 HR, 1…

Perrigo Company PLC · Allegan, MI

Risk level
Class II
Reported by FDA
Jan 12, 2022
Recall ID
D-0331-2022
Check your lot numberHow we source this data

Summary

Perrigo recalled basic+care starting Jul 27, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0331-2022 on Jan 12, 2022. Reason: Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Product description

basic+care, allergy Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 24 HR, 150 count bottle, Made in the Czech Republic, Distributed by: Perrigo Allergan, MI 49010, NDC 0113-7571-47 UPC 3 70030 11470 2

Lot numbers, UPCs & expiration codes

Lot # 0GR0528, Exp 03/31/22; 0KR0473, Exp 04/30/22; 0LR0369, Exp 06/30/22

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0331-2022
Classification
Class II
Status
Terminated
Recall initiated
Jul 27, 2021
FDA report date
Jan 12, 2022
Quantity
28,320 containers
Recall type
Voluntary: Firm initiated
Recalling firm
Perrigo Company PLC

Original FDA data

Every field from FDA enforcement report D-0331-2022, exactly as published.

Show all FDA fields
City
Allegan
State
MI
Status
Terminated
Country
United States
Event ID
88384
Address
515 Eastern Ave
Code information
Lot # 0GR0528, Exp 03/31/22; 0KR0473, Exp 04/30/22; 0LR0369, Exp 06/30/22
Postal code
49010-9070
Report date
Jan 12, 2022
Product type
Drugs
Recall number
D-0331-2022
Classification
Class II
Recalling firm
Perrigo Company PLC
Product quantity
28,320 containers
Termination date
Nov 8, 2022
Reason for recall
Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
basic+care, allergy Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 24 HR, 150 count bottle, Made in the Czech Republic, Distributed by: Perrigo Allergan, MI 49010, NDC 0113-7571-47 UPC 3 70030 11470 2
Distribution pattern
Nationwide in the USA
Recall initiation date
Jul 27, 2021
Initial firm notification
Letter
Center classification date
Jan 5, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0331-2022, published Jan 12, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls